Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 10—October 2019
CME ACTIVITY - Synopsis

Edwardsiella tarda Bacteremia, Okayama, Japan, 2005–2016

Shinya KamiyamaComments to Author , Akira Kuriyama, and Toru Hashimoto
Author affiliations: Kurashiki Central Hospital, Okayama, Japan

Main Article

Table 3

Comparison of characteristics of patients with bacteremic and nonbacteremic Edwardsiella tarda infection, Kurashiki Central Hospital, Okayama, Japan, 2005–2016*

Patient characteristic Patients with bacteremic infection, n = 26 Patients with nonbacteremic infection, n = 124 p value
Median age, y (IQR) [range]
75 (63–85) [45–101]
56 (12–73) [0- 89]
<0.001
Sex, no. patients
M 13 82 0.178
F
13
42

Underlying disease, no. patients
Solid tumor 12 22 0.004
Cardiovascular disease 4 22 1.00
Diabetes mellitus 3 13 1.00
Gallstone 3 13 1.00
Chronic liver disease 2 7 0.65
Cerebrovascular disease 2 1 0.078
Hematologic malignancy 1 1 0.32
Chronic kidney disease 0 1 1.00
Ulcerative colitis 0 14 0.13
Crohn disease 0 1 1.00
None 4 52 0.013
Other
0
2
1.00
Behavioral/dietary risk factors, no. patients
Alcoholism 4 9 0.24
Exposure to raw food 3 7 0.38
Exposure to fresh or marine water, animal feces
1
0
0.173
Clinical diagnosis, no. patients
Cholangitis 9 8 <0.001
Liver abscess 6 1 <0.001
Enterocolitis 4 74 0.076
Cholecystitis 3 9 0.44
Spontaneous bacterial peritonitis 1 0 0.173
Mycotic aneurysm 1 1 0.32
Necrotizing fasciitis 1 0 0.173
Empyema 1 0 0.173
Febrile neutropenia 1 0 0.173
Osteomyelitis 1 0 0.173
Secondary peritonitis 1 0 0.173
Focus unknown 5 1 0.001
Endometriosis 0 1 1.00
Appendicitis 0 4 1.00
Congenital infection 0 1 1.00
Cystitis 0 1 1.00
Intraabdominal abscess 0 1 1.00
Perianal abscess 0 1 1.00
Pneumonia 0 2 1.00
Pyometra 0 1 1.00
Secondary peritonitis 0 2 1.00
Superficial surgical site infection
0
1
1.00
Receipt of chemotherapy for cancer, no. patients
4
7
0.099
Median duration of treatment for infection, d (IQR) [range] 12 (7–27) [1–77] 5 (3–9) [0–36] <0.001

*IQR, interquartile range.

Main Article

Page created: September 12, 2019
Page updated: September 12, 2019
Page reviewed: September 12, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external